Grading of neuropathology in multiple system atrophy: Proposal for a novel scale
Identifieur interne : 004F90 ( Main/Merge ); précédent : 004F89; suivant : 004F91Grading of neuropathology in multiple system atrophy: Proposal for a novel scale
Auteurs : Kurt A. Jellinger [Autriche] ; Klaus Seppi [Autriche] ; Gregor K. Wenning [Autriche]Source :
- Movement Disorders [ 0885-3185 ] ; 2005-08.
English descriptors
- KwdEn :
- Cerebellar Ataxia (epidemiology), Corpus Striatum (metabolism), Corpus Striatum (pathology), Diagnosis, Differential, Disease Progression, Humans, Middle Aged, Multiple System Atrophy (epidemiology), Multiple System Atrophy (metabolism), Multiple System Atrophy (pathology), Nerve Degeneration (epidemiology), Nerve Degeneration (pathology), Olivopontocerebellar Atrophies (epidemiology), Olivopontocerebellar Atrophies (pathology), Severity of Illness Index, alpha-Synuclein (metabolism), clinicopathological correlations, grading, multiple system atrophy, neuropathology, olivopontocerebellar atrophy, striatonigral degeneration.
- MESH :
- chemical , metabolism : alpha-Synuclein.
- epidemiology : Cerebellar Ataxia, Multiple System Atrophy, Nerve Degeneration, Olivopontocerebellar Atrophies.
- metabolism : Corpus Striatum, Multiple System Atrophy.
- pathology : Corpus Striatum, Multiple System Atrophy, Nerve Degeneration, Olivopontocerebellar Atrophies.
- Diagnosis, Differential, Disease Progression, Humans, Middle Aged, Severity of Illness Index.
Abstract
Multiple system atrophy (MSA), a sporadic progressive synucleinopathy of advanced age, is separated into two clinic opathological subtypes: MSA‐P (striatonigral degeneration [SND]) with predominant parkinsonian features and MSA‐C (olivopontocerebellar atrophy [OPCA]) with predominant cerebellar ataxia. We propose a novel morphological grading system for both subtypes to compare lesion intensities and their possible clinical validity. Forty‐two autopsy cases of MSA were separated into four grades (SND 0–III and OPCA 0–III) based on semiquantitative assessment of neuronal loss, astrogliosis, and presence of α‐synuclein‐positive glial cytoplasmic inclusions (GCI) in striatum, globus pallidus, substantia nigra, pontine basis, cerebellum, and inferior olives. Whereas a recent grading system restricted to SND reflected disease progression and dopa‐responsiveness, there was considerable variation in the morphological combination between SND and OPCA, with only around half the cases with OPCA II (moderate) and III (severe) showing comparable grades of both types, whereas OPCA 0 and I (no or little degeneration) was combined with all grades of SND. Twenty‐two cases showing OPCA 0 + SND II (n = 3), OPCA I + SND I–II (n = 11), and OPCA I + SND III (n = 8) were classified as pure or predominant SND, consistent with MSA‐P. Twenty cases showing OPCA II + SND II/III (n = 7) and OPCA III + SND III (n = 13) were classified as predominant OPCA, consistent with MSA‐C. In MSA‐P, the mean age of onset was higher than it was in MSA‐C (55.1 vs. 50.5 years), but the mean duration of illness was shorter in MSA‐P (5.3 vs. 6.7 years). Presenting symptoms in MSA‐P were mainly parkinsonism, whereas in MSA‐C they were mainly gait disorders (14 vs. 1; P < 0.001). Among clinical key symptoms, parkinsonism was more frequent than were cerebellar signs in MSA‐P; in MSA‐C it was the reverse (P < 0.01), whereas other symptoms (autonomic/urinary failure) showed no differences. Parkinsonism was infrequent in MSA‐C even when OPCA was associated with SND, suggesting a masking effect by cerebellar system involvement. High terminal Hoehn and Yahr stages were more frequent in MSA‐P (P < 0.01), some with good‐to‐moderate initial levodopa (L‐dopa) response. Although the proposed morphological grading of both MSA‐P and ‐C correlates well with initial symptoms and clinical key features of both types, further prospective studies are required to validate the clinical utility of the proposed MSA grading scales for future intervention studies. © 2005 Movement Disorder Society
Url:
DOI: 10.1002/mds.20537
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 000B42
- to stream Istex, to step Curation: 000B42
- to stream Istex, to step Checkpoint: 002313
- to stream PubMed, to step Corpus: 002F39
- to stream PubMed, to step Curation: 002F39
- to stream PubMed, to step Checkpoint: 003116
- to stream Ncbi, to step Merge: 001373
- to stream Ncbi, to step Curation: 001373
- to stream Ncbi, to step Checkpoint: 001373
Links to Exploration step
ISTEX:85BA975FD3AD2A765CD76049CDCE2034654E4545Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Grading of neuropathology in multiple system atrophy: Proposal for a novel scale</title>
<author><name sortKey="Jellinger, Kurt A" sort="Jellinger, Kurt A" uniqKey="Jellinger K" first="Kurt A." last="Jellinger">Kurt A. Jellinger</name>
</author>
<author><name sortKey="Seppi, Klaus" sort="Seppi, Klaus" uniqKey="Seppi K" first="Klaus" last="Seppi">Klaus Seppi</name>
</author>
<author><name sortKey="Wenning, Gregor K" sort="Wenning, Gregor K" uniqKey="Wenning G" first="Gregor K." last="Wenning">Gregor K. Wenning</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:85BA975FD3AD2A765CD76049CDCE2034654E4545</idno>
<date when="2005" year="2005">2005</date>
<idno type="doi">10.1002/mds.20537</idno>
<idno type="url">https://api.istex.fr/document/85BA975FD3AD2A765CD76049CDCE2034654E4545/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000B42</idno>
<idno type="wicri:Area/Istex/Curation">000B42</idno>
<idno type="wicri:Area/Istex/Checkpoint">002313</idno>
<idno type="wicri:doubleKey">0885-3185:2005:Jellinger K:grading:of:neuropathology</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:16092088</idno>
<idno type="wicri:Area/PubMed/Corpus">002F39</idno>
<idno type="wicri:Area/PubMed/Curation">002F39</idno>
<idno type="wicri:Area/PubMed/Checkpoint">003116</idno>
<idno type="wicri:Area/Ncbi/Merge">001373</idno>
<idno type="wicri:Area/Ncbi/Curation">001373</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">001373</idno>
<idno type="wicri:doubleKey">0885-3185:2005:Jellinger K:grading:of:neuropathology</idno>
<idno type="wicri:Area/Main/Merge">004F90</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Grading of neuropathology in multiple system atrophy: Proposal for a novel scale</title>
<author><name sortKey="Jellinger, Kurt A" sort="Jellinger, Kurt A" uniqKey="Jellinger K" first="Kurt A." last="Jellinger">Kurt A. Jellinger</name>
<affiliation wicri:level="3"><country xml:lang="fr">Autriche</country>
<wicri:regionArea>Institute of Clinical Neurobiology, Vienna</wicri:regionArea>
<placeName><settlement type="city">Vienne (Autriche)</settlement>
<region nuts="2" type="province">Vienne (Autriche)</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Seppi, Klaus" sort="Seppi, Klaus" uniqKey="Seppi K" first="Klaus" last="Seppi">Klaus Seppi</name>
<affiliation wicri:level="1"><country xml:lang="fr">Autriche</country>
<wicri:regionArea>Department of Neurology, University of Innsbruck School of Medicine, Innsbruck</wicri:regionArea>
<wicri:noRegion>Innsbruck</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Wenning, Gregor K" sort="Wenning, Gregor K" uniqKey="Wenning G" first="Gregor K." last="Wenning">Gregor K. Wenning</name>
<affiliation wicri:level="1"><country xml:lang="fr">Autriche</country>
<wicri:regionArea>Department of Neurology, University of Innsbruck School of Medicine, Innsbruck</wicri:regionArea>
<wicri:noRegion>Innsbruck</wicri:noRegion>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Movement Disorders</title>
<title level="j" type="sub">Official Journal of the Movement Disorder Society</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="ISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="2005-08">2005-08</date>
<biblScope unit="vol">20</biblScope>
<biblScope unit="issue">S12</biblScope>
<biblScope unit="supplement">S12</biblScope>
<biblScope unit="page" from="S29">S29</biblScope>
<biblScope unit="page" to="S36">S36</biblScope>
</imprint>
<idno type="ISSN">0885-3185</idno>
</series>
<idno type="istex">85BA975FD3AD2A765CD76049CDCE2034654E4545</idno>
<idno type="DOI">10.1002/mds.20537</idno>
<idno type="ArticleID">MDS20537</idno>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Cerebellar Ataxia (epidemiology)</term>
<term>Corpus Striatum (metabolism)</term>
<term>Corpus Striatum (pathology)</term>
<term>Diagnosis, Differential</term>
<term>Disease Progression</term>
<term>Humans</term>
<term>Middle Aged</term>
<term>Multiple System Atrophy (epidemiology)</term>
<term>Multiple System Atrophy (metabolism)</term>
<term>Multiple System Atrophy (pathology)</term>
<term>Nerve Degeneration (epidemiology)</term>
<term>Nerve Degeneration (pathology)</term>
<term>Olivopontocerebellar Atrophies (epidemiology)</term>
<term>Olivopontocerebellar Atrophies (pathology)</term>
<term>Severity of Illness Index</term>
<term>alpha-Synuclein (metabolism)</term>
<term>clinicopathological correlations</term>
<term>grading</term>
<term>multiple system atrophy</term>
<term>neuropathology</term>
<term>olivopontocerebellar atrophy</term>
<term>striatonigral degeneration</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en"><term>alpha-Synuclein</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Cerebellar Ataxia</term>
<term>Multiple System Atrophy</term>
<term>Nerve Degeneration</term>
<term>Olivopontocerebellar Atrophies</term>
</keywords>
<keywords scheme="MESH" qualifier="metabolism" xml:lang="en"><term>Corpus Striatum</term>
<term>Multiple System Atrophy</term>
</keywords>
<keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Corpus Striatum</term>
<term>Multiple System Atrophy</term>
<term>Nerve Degeneration</term>
<term>Olivopontocerebellar Atrophies</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Diagnosis, Differential</term>
<term>Disease Progression</term>
<term>Humans</term>
<term>Middle Aged</term>
<term>Severity of Illness Index</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Multiple system atrophy (MSA), a sporadic progressive synucleinopathy of advanced age, is separated into two clinic opathological subtypes: MSA‐P (striatonigral degeneration [SND]) with predominant parkinsonian features and MSA‐C (olivopontocerebellar atrophy [OPCA]) with predominant cerebellar ataxia. We propose a novel morphological grading system for both subtypes to compare lesion intensities and their possible clinical validity. Forty‐two autopsy cases of MSA were separated into four grades (SND 0–III and OPCA 0–III) based on semiquantitative assessment of neuronal loss, astrogliosis, and presence of α‐synuclein‐positive glial cytoplasmic inclusions (GCI) in striatum, globus pallidus, substantia nigra, pontine basis, cerebellum, and inferior olives. Whereas a recent grading system restricted to SND reflected disease progression and dopa‐responsiveness, there was considerable variation in the morphological combination between SND and OPCA, with only around half the cases with OPCA II (moderate) and III (severe) showing comparable grades of both types, whereas OPCA 0 and I (no or little degeneration) was combined with all grades of SND. Twenty‐two cases showing OPCA 0 + SND II (n = 3), OPCA I + SND I–II (n = 11), and OPCA I + SND III (n = 8) were classified as pure or predominant SND, consistent with MSA‐P. Twenty cases showing OPCA II + SND II/III (n = 7) and OPCA III + SND III (n = 13) were classified as predominant OPCA, consistent with MSA‐C. In MSA‐P, the mean age of onset was higher than it was in MSA‐C (55.1 vs. 50.5 years), but the mean duration of illness was shorter in MSA‐P (5.3 vs. 6.7 years). Presenting symptoms in MSA‐P were mainly parkinsonism, whereas in MSA‐C they were mainly gait disorders (14 vs. 1; P < 0.001). Among clinical key symptoms, parkinsonism was more frequent than were cerebellar signs in MSA‐P; in MSA‐C it was the reverse (P < 0.01), whereas other symptoms (autonomic/urinary failure) showed no differences. Parkinsonism was infrequent in MSA‐C even when OPCA was associated with SND, suggesting a masking effect by cerebellar system involvement. High terminal Hoehn and Yahr stages were more frequent in MSA‐P (P < 0.01), some with good‐to‐moderate initial levodopa (L‐dopa) response. Although the proposed morphological grading of both MSA‐P and ‐C correlates well with initial symptoms and clinical key features of both types, further prospective studies are required to validate the clinical utility of the proposed MSA grading scales for future intervention studies. © 2005 Movement Disorder Society</div>
</front>
</TEI>
<double doi="10.1002/mds.20537"><ISTEX><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Grading of neuropathology in multiple system atrophy: Proposal for a novel scale</title>
<author><name sortKey="Jellinger, Kurt A" sort="Jellinger, Kurt A" uniqKey="Jellinger K" first="Kurt A." last="Jellinger">Kurt A. Jellinger</name>
</author>
<author><name sortKey="Seppi, Klaus" sort="Seppi, Klaus" uniqKey="Seppi K" first="Klaus" last="Seppi">Klaus Seppi</name>
</author>
<author><name sortKey="Wenning, Gregor K" sort="Wenning, Gregor K" uniqKey="Wenning G" first="Gregor K." last="Wenning">Gregor K. Wenning</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:85BA975FD3AD2A765CD76049CDCE2034654E4545</idno>
<date when="2005" year="2005">2005</date>
<idno type="doi">10.1002/mds.20537</idno>
<idno type="url">https://api.istex.fr/document/85BA975FD3AD2A765CD76049CDCE2034654E4545/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000B42</idno>
<idno type="wicri:Area/Istex/Curation">000B42</idno>
<idno type="wicri:Area/Istex/Checkpoint">002313</idno>
<idno type="wicri:doubleKey">0885-3185:2005:Jellinger K:grading:of:neuropathology</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Grading of neuropathology in multiple system atrophy: Proposal for a novel scale</title>
<author><name sortKey="Jellinger, Kurt A" sort="Jellinger, Kurt A" uniqKey="Jellinger K" first="Kurt A." last="Jellinger">Kurt A. Jellinger</name>
<affiliation wicri:level="3"><country xml:lang="fr">Autriche</country>
<wicri:regionArea>Institute of Clinical Neurobiology, Vienna</wicri:regionArea>
<placeName><settlement type="city">Vienne (Autriche)</settlement>
<region nuts="2" type="province">Vienne (Autriche)</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Seppi, Klaus" sort="Seppi, Klaus" uniqKey="Seppi K" first="Klaus" last="Seppi">Klaus Seppi</name>
<affiliation wicri:level="1"><country xml:lang="fr">Autriche</country>
<wicri:regionArea>Department of Neurology, University of Innsbruck School of Medicine, Innsbruck</wicri:regionArea>
<wicri:noRegion>Innsbruck</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Wenning, Gregor K" sort="Wenning, Gregor K" uniqKey="Wenning G" first="Gregor K." last="Wenning">Gregor K. Wenning</name>
<affiliation wicri:level="1"><country xml:lang="fr">Autriche</country>
<wicri:regionArea>Department of Neurology, University of Innsbruck School of Medicine, Innsbruck</wicri:regionArea>
<wicri:noRegion>Innsbruck</wicri:noRegion>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Movement Disorders</title>
<title level="j" type="sub">Official Journal of the Movement Disorder Society</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="ISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="2005-08">2005-08</date>
<biblScope unit="vol">20</biblScope>
<biblScope unit="issue">S12</biblScope>
<biblScope unit="supplement">S12</biblScope>
<biblScope unit="page" from="S29">S29</biblScope>
<biblScope unit="page" to="S36">S36</biblScope>
</imprint>
<idno type="ISSN">0885-3185</idno>
</series>
<idno type="istex">85BA975FD3AD2A765CD76049CDCE2034654E4545</idno>
<idno type="DOI">10.1002/mds.20537</idno>
<idno type="ArticleID">MDS20537</idno>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>clinicopathological correlations</term>
<term>grading</term>
<term>multiple system atrophy</term>
<term>neuropathology</term>
<term>olivopontocerebellar atrophy</term>
<term>striatonigral degeneration</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Multiple system atrophy (MSA), a sporadic progressive synucleinopathy of advanced age, is separated into two clinic opathological subtypes: MSA‐P (striatonigral degeneration [SND]) with predominant parkinsonian features and MSA‐C (olivopontocerebellar atrophy [OPCA]) with predominant cerebellar ataxia. We propose a novel morphological grading system for both subtypes to compare lesion intensities and their possible clinical validity. Forty‐two autopsy cases of MSA were separated into four grades (SND 0–III and OPCA 0–III) based on semiquantitative assessment of neuronal loss, astrogliosis, and presence of α‐synuclein‐positive glial cytoplasmic inclusions (GCI) in striatum, globus pallidus, substantia nigra, pontine basis, cerebellum, and inferior olives. Whereas a recent grading system restricted to SND reflected disease progression and dopa‐responsiveness, there was considerable variation in the morphological combination between SND and OPCA, with only around half the cases with OPCA II (moderate) and III (severe) showing comparable grades of both types, whereas OPCA 0 and I (no or little degeneration) was combined with all grades of SND. Twenty‐two cases showing OPCA 0 + SND II (n = 3), OPCA I + SND I–II (n = 11), and OPCA I + SND III (n = 8) were classified as pure or predominant SND, consistent with MSA‐P. Twenty cases showing OPCA II + SND II/III (n = 7) and OPCA III + SND III (n = 13) were classified as predominant OPCA, consistent with MSA‐C. In MSA‐P, the mean age of onset was higher than it was in MSA‐C (55.1 vs. 50.5 years), but the mean duration of illness was shorter in MSA‐P (5.3 vs. 6.7 years). Presenting symptoms in MSA‐P were mainly parkinsonism, whereas in MSA‐C they were mainly gait disorders (14 vs. 1; P < 0.001). Among clinical key symptoms, parkinsonism was more frequent than were cerebellar signs in MSA‐P; in MSA‐C it was the reverse (P < 0.01), whereas other symptoms (autonomic/urinary failure) showed no differences. Parkinsonism was infrequent in MSA‐C even when OPCA was associated with SND, suggesting a masking effect by cerebellar system involvement. High terminal Hoehn and Yahr stages were more frequent in MSA‐P (P < 0.01), some with good‐to‐moderate initial levodopa (L‐dopa) response. Although the proposed morphological grading of both MSA‐P and ‐C correlates well with initial symptoms and clinical key features of both types, further prospective studies are required to validate the clinical utility of the proposed MSA grading scales for future intervention studies. © 2005 Movement Disorder Society</div>
</front>
</TEI>
</ISTEX>
<PubMed><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Grading of neuropathology in multiple system atrophy: proposal for a novel scale.</title>
<author><name sortKey="Jellinger, Kurt A" sort="Jellinger, Kurt A" uniqKey="Jellinger K" first="Kurt A" last="Jellinger">Kurt A. Jellinger</name>
<affiliation wicri:level="3"><nlm:affiliation>Institute of Clinical Neurobiology, Vienna, Austria. kurt.jellinger@univie.ac.at</nlm:affiliation>
<country xml:lang="fr">Autriche</country>
<wicri:regionArea>Institute of Clinical Neurobiology, Vienna</wicri:regionArea>
<placeName><settlement type="city">Vienne (Autriche)</settlement>
<region nuts="2" type="province">Vienne (Autriche)</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Seppi, Klaus" sort="Seppi, Klaus" uniqKey="Seppi K" first="Klaus" last="Seppi">Klaus Seppi</name>
</author>
<author><name sortKey="Wenning, Gregor K" sort="Wenning, Gregor K" uniqKey="Wenning G" first="Gregor K" last="Wenning">Gregor K. Wenning</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2005">2005</date>
<idno type="doi">10.1002/mds.20537</idno>
<idno type="RBID">pubmed:16092088</idno>
<idno type="pmid">16092088</idno>
<idno type="wicri:Area/PubMed/Corpus">002F39</idno>
<idno type="wicri:Area/PubMed/Curation">002F39</idno>
<idno type="wicri:Area/PubMed/Checkpoint">003116</idno>
<idno type="wicri:Area/Ncbi/Merge">001373</idno>
<idno type="wicri:Area/Ncbi/Curation">001373</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">001373</idno>
<idno type="wicri:doubleKey">0885-3185:2005:Jellinger K:grading:of:neuropathology</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Grading of neuropathology in multiple system atrophy: proposal for a novel scale.</title>
<author><name sortKey="Jellinger, Kurt A" sort="Jellinger, Kurt A" uniqKey="Jellinger K" first="Kurt A" last="Jellinger">Kurt A. Jellinger</name>
<affiliation wicri:level="3"><nlm:affiliation>Institute of Clinical Neurobiology, Vienna, Austria. kurt.jellinger@univie.ac.at</nlm:affiliation>
<country xml:lang="fr">Autriche</country>
<wicri:regionArea>Institute of Clinical Neurobiology, Vienna</wicri:regionArea>
<placeName><settlement type="city">Vienne (Autriche)</settlement>
<region nuts="2" type="province">Vienne (Autriche)</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Seppi, Klaus" sort="Seppi, Klaus" uniqKey="Seppi K" first="Klaus" last="Seppi">Klaus Seppi</name>
</author>
<author><name sortKey="Wenning, Gregor K" sort="Wenning, Gregor K" uniqKey="Wenning G" first="Gregor K" last="Wenning">Gregor K. Wenning</name>
</author>
</analytic>
<series><title level="j">Movement disorders : official journal of the Movement Disorder Society</title>
<idno type="ISSN">0885-3185</idno>
<imprint><date when="2005" type="published">2005</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Cerebellar Ataxia (epidemiology)</term>
<term>Corpus Striatum (metabolism)</term>
<term>Corpus Striatum (pathology)</term>
<term>Diagnosis, Differential</term>
<term>Disease Progression</term>
<term>Humans</term>
<term>Middle Aged</term>
<term>Multiple System Atrophy (epidemiology)</term>
<term>Multiple System Atrophy (metabolism)</term>
<term>Multiple System Atrophy (pathology)</term>
<term>Nerve Degeneration (epidemiology)</term>
<term>Nerve Degeneration (pathology)</term>
<term>Olivopontocerebellar Atrophies (epidemiology)</term>
<term>Olivopontocerebellar Atrophies (pathology)</term>
<term>Severity of Illness Index</term>
<term>alpha-Synuclein (metabolism)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en"><term>alpha-Synuclein</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Cerebellar Ataxia</term>
<term>Multiple System Atrophy</term>
<term>Nerve Degeneration</term>
<term>Olivopontocerebellar Atrophies</term>
</keywords>
<keywords scheme="MESH" qualifier="metabolism" xml:lang="en"><term>Corpus Striatum</term>
<term>Multiple System Atrophy</term>
</keywords>
<keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Corpus Striatum</term>
<term>Multiple System Atrophy</term>
<term>Nerve Degeneration</term>
<term>Olivopontocerebellar Atrophies</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Diagnosis, Differential</term>
<term>Disease Progression</term>
<term>Humans</term>
<term>Middle Aged</term>
<term>Severity of Illness Index</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Multiple system atrophy (MSA), a sporadic progressive synucleinopathy of advanced age, is separated into two clinic opathological subtypes: MSA-P (striatonigral degeneration [SND]) with predominant parkinsonian features and MSA-C (olivopontocerebellar atrophy [OPCA]) with predominant cerebellar ataxia. We propose a novel morphological grading system for both subtypes to compare lesion intensities and their possible clinical validity. Forty-two autopsy cases of MSA were separated into four grades (SND 0-III and OPCA 0-III) based on semiquantitative assessment of neuronal loss, astrogliosis, and presence of alpha-synuclein-positive glial cytoplasmic inclusions (GCI) in striatum, globus pallidus, substantia nigra, pontine basis, cerebellum, and inferior olives. Whereas a recent grading system restricted to SND reflected disease progression and dopa-responsiveness, there was considerable variation in the morphological combination between SND and OPCA, with only around half the cases with OPCA II (moderate) and III (severe) showing comparable grades of both types, whereas OPCA 0 and I (no or little degeneration) was combined with all grades of SND. Twenty-two cases showing OPCA 0 + SND II (n = 3), OPCA I + SND I-II (n = 11), and OPCA I + SND III (n = 8) were classified as pure or predominant SND, consistent with MSA-P. Twenty cases showing OPCA II + SND II/III (n = 7) and OPCA III + SND III (n = 13) were classified as predominant OPCA, consistent with MSA-C. In MSA-P, the mean age of onset was higher than it was in MSA-C (55.1 vs. 50.5 years), but the mean duration of illness was shorter in MSA-P (5.3 vs. 6.7 years). Presenting symptoms in MSA-P were mainly parkinsonism, whereas in MSA-C they were mainly gait disorders (14 vs. 1; P < 0.001). Among clinical key symptoms, parkinsonism was more frequent than were cerebellar signs in MSA-P; in MSA-C it was the reverse (P < 0.01), whereas other symptoms (autonomic/urinary failure) showed no differences. Parkinsonism was infrequent in MSA-C even when OPCA was associated with SND, suggesting a masking effect by cerebellar system involvement. High terminal Hoehn and Yahr stages were more frequent in MSA-P (P < 0.01), some with good-to-moderate initial levodopa (L-dopa) response. Although the proposed morphological grading of both MSA-P and -C correlates well with initial symptoms and clinical key features of both types, further prospective studies are required to validate the clinical utility of the proposed MSA grading scales for future intervention studies.</div>
</front>
</TEI>
</PubMed>
</double>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 004F90 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Merge/biblio.hfd -nk 004F90 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Santé |area= MovDisordV3 |flux= Main |étape= Merge |type= RBID |clé= ISTEX:85BA975FD3AD2A765CD76049CDCE2034654E4545 |texte= Grading of neuropathology in multiple system atrophy: Proposal for a novel scale }}
![]() | This area was generated with Dilib version V0.6.23. | ![]() |